The following table provides an overview of the latest patents of Altergon S.a. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3056187Aug 30, 2023Single-Dose Pharmaceutical Preparation Of Thyroid Hormones T3 And/Or T41
EP2034956Jun 28, 2023Compositions Comprising Glycosaminoglycans Of Low Viscosity And Use Of Said Composition In Therapy Of Chronic Cystitis1
EP3528847Jul 22, 2020High-Stability Packaged Solutions Of T4 Thyroid Hormone1